Entia

London, United Kingdom Founded: 2012 • Age: 14 yrs
Point-of-care devices for blood analysis are developed and provided.

About Entia

Entia is a company based in London (United Kingdom) founded in 2012.. Entia has raised $41.29 million across 8 funding rounds from investors including Oxford Technology, BGF and Parkwalk. The company has 28 employees as of March 31, 2021. Entia offers products and services including Liberty. Entia operates in a competitive market with competitors including HORIBA, Quotient Biodiagnostics, Boule Diagnostics, FYR Diagnostics and Mursla, among others.

  • Headquarter London, United Kingdom
  • Employees 28 as on 31 Mar, 2021
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Entia Ltd
  • Date of Incorporation 28 Oct, 2014
  • Jurisdiction LONDON
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $41.29 M (USD)

    in 8 rounds

  • Latest Funding Round
    $20.66 M (USD), Series A

    Jul 27, 2023

  • Investors
  • Employee Count
    28

    as on Mar 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Entia

Entia offers a comprehensive portfolio of products and services, including Liberty. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

At-home solution for blood tests to support cancer care monitoring.

People of Entia
Headcount 10-50
Employee Profiles 12
Employee Profiles
People
Toby Basey-Fisher
Co-Founder & CEO
People
Hannah Rawlinson-Smith
Clinical Project Manager
People
Laura Barrera Moreno
Research Manager
People
Chris Burrows
CTO

Unlock access to complete

Funding Insights of Entia

Entia has successfully raised a total of $41.29M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $20.66 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series A — $20.7M
  • First Round

    (19 May 2016)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2023 Amount Series A - Entia Valuation BGF
Aug, 2022 Amount Series A - Entia Valuation

investors

Apr, 2021 Amount Series A - Entia Valuation BGF , Parkwalk
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Entia

Entia has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Technology, BGF and Parkwalk. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
Founded Year Domain Location
Tech companies are invested in by Parkwalk venture capital firm.
Founded Year Domain Location
Early-stage micro-VC investments are focused on UK companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Entia

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Entia

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Entia Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Entia

Entia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HORIBA, Quotient Biodiagnostics, Boule Diagnostics, FYR Diagnostics and Mursla, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multinational conglomerate
domain founded_year HQ Location
Manufacturer of immunohematology products for use in transfusion diagnostics
domain founded_year HQ Location
Provider of blood count analyzer for human and veterinary applications
domain founded_year HQ Location
In-vitro diagnostic tests for disease detection are provided.
domain founded_year HQ Location
Diagnostic devices for cancer detection are developed using nanostructures.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Entia

Frequently Asked Questions about Entia

When was Entia founded?

Entia was founded in 2012 and raised its 1st funding round 4 years after it was founded.

Where is Entia located?

Entia is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Is Entia a funded company?

Entia is a funded company, having raised a total of $41.29M across 8 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on May 19, 2016.

How many employees does Entia have?

As of Mar 31, 2021, the latest employee count at Entia is 28.

What does Entia do?

Entia was founded in 2012 and is based in London, United Kingdom. Operations focus on the medical diagnostics sector, where point-of-care devices for blood testing are developed. The flagship product, Aptus, utilizes a single drop of blood from capillary, venous, or arterial sources to assess hemoglobin levels and hematocrit. Affinity, another device in development, enables complete blood counts to be performed at the point of care or in home settings.

Who are the top competitors of Entia?

Entia's top competitors include HORIBA, Quotient Biodiagnostics and Boule Diagnostics.

What products or services does Entia offer?

Entia offers Liberty.

Who are Entia's investors?

Entia has 5 investors. Key investors include Oxford Technology, BGF, Parkwalk, Innovate UK, and Sussex Place Ventures.

What is Entia's valuation?

The valuation of Entia is $3.37M as of Aug 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available